Tag Archives: resistant cancer

Multi-Drug Resistance in Cancer: Data Analysis for P-glycoprotein Inhibition

Drug efflux and P-glycoprotein Over time, cancerous cells have the ability to become resistant to treatments such as chemotherapy through several mechanisms. One of them is drug efflux, an otherwise useful body mechanism that protects normal cells by ensuring the intracellular drug concentration stays below a cell-killing threshold. Drug efflux is possible thanks to proteins… Read More »